N/A
N=26
Effectiveness and Neuropsychological Predictors of Guided Self-Help for Obsessive-Compulsive Disorder (OCD)
Obsessive-Compulsive Disorder
Bottom Line
View on ClinicalTrials.gov: NCT01659125 ↗Enrolled (actual)
26
Serious AEs
4.2%
Results posted
Jan 2016
Primary outcome: Primary: Change in Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) — 24.67; 18.29; 18.46 units on a scale
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- "OCFighter" (Behavioral)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Hartford Hospital
- Primary completion
- Jun 2014
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Change in Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) |
24.67; 18.29; 18.46 | — |
| PRIMARY Responder Status |
5; 5 | — |
Summary
The primary aim of this study is to learn about who is most likely to benefit from guided self-help (GSH) for obsessive-compulsive disorder (OCD).
Eligibility Criteria
Inclusion Criteria
- Principal or co-principal diagnosis of OCD
- Clinical global impression score greater than or equal to 4
- Y-BOCS score great than or equal to 8
- Fluency in English
- Capacity to understand the nature of the study and willingness to sign informed consent form
Exclusion Criteria
- Active manic episode, psychosis, pervasive developmental disorder, mental retardation
- Concurrent OCD psychotherapy
- Current threat of harm to self or others
- Previous adequate trial of therapist-administered or self-administered exposure and response prevention for OCD
Data sourced from ClinicalTrials.gov (NCT01659125). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.